$CYDY CytoDyn Annual shareholders meeting discus
Post# of 9163
![Avatar](/images/ProfileImages/41844432_59930_FEED91F3-83D0-4093-A825-39F60E596C00.gif)
Annual shareholders meeting discussed Leronlimab (PRO 140)
The U.S. Food and Drug Administration (FDA) has granted a “Fast Track” designation to CytoDyn for two potential indications of leronlimab for deadly diseases.
https://www.cytodyn.com/newsroom/press-releas...meeting-of
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)